News

Find News

Filter articles

Showing 1 to 10 of 2001 results

FTC antitrust charges against Impax dismissed

US25-05-2018

A judge has found it unlikely that Impax Laboratories would launch a generic drug before a final court decision in related patent litigation and has dismissed a case against the company.  

Fed Circuit sides with district court in UCB win against generics

US24-05-2018

Pharmaceutical company UCB has emerged victorious in a case against major generic drug companies after its patent win was affirmed on appeal.

Boehringer seeks injunction in pig vaccine case

US23-05-2018

Animal health company Boehringer Ingelheim Vetmedica has sued Merck & Co and Merck Animal Health for infringing three patents covering vaccines for treating pig disease.

DowDuPont unit and Monsanto sign insect licensing deal

Canada, US23-05-2018

Corteva Agriscience, the agriculture division of DowDuPont, has signed a licensing deal with Monsanto to use its technology for fighting insects found on corn.

Lundbeck and Takeda take on Lupin over anti-depressant ANDA

US23-05-2018

Pharmaceutical companies Lundbeck and Takeda have sued generic drug producer Lupin for infringing a patent directed to anti-depressant medication Trintellix (vortioxetine hydrobromide).

UKIPO issues formal response to Industrial Strategy IP views

UK22-05-2018

The UK Intellectual Property Office has published several proposals, including some addressing barriers to growth for IP-rich companies, in response to received views of IP with regard to the government’s Industrial Strategy.

FDA identifies companies ‘potentially blocking access’ to drug samples

US21-05-2018

The US Food and Drug Administration has published a list of companies that it suspects might be preventing generic drug producers accessing samples of branded products.

Federal Circuit affirms Praxair patent victory against Mallinckrodt

US21-05-2018

The US Court of Appeals for the Federal Circuit has affirmed a patent victory for industrial gases company Praxair against pharmaceutical business Mallinckrodt.

Novartis acquires gene therapy company

18-05-2018Mergers & acquisitions

Novartis has acquired clinical-stage gene therapy company AveXis.

Pharmacies hit Allergan with Restasis competition claims

US17-05-2018

Four US pharmacies have filed an antitrust lawsuit against Allergan over the drug company’s “unlawful scheme” to maintain its patent monopoly over dry-eye treatment Restasis (cyclosporine ophthalmic emulsion).

Showing 1 to 10 of 2001 results

LSIPR